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Abstract  
Background: Multiple sclerosis is a chronic demyelinating disease of the central nervous system. The patient’s state is deter-
mined by factors such as the type of MS, the time since diagnosis, family support and many other individual characteristics. 
The prolonged and progressive nature of the disease leads to a decrease in the quality of life and the gradual deterioration of  
a patient’s functional state. 
Purpose: The aim of this study was to evaluate the quality of life in people with multiple sclerosis and to determine the rela-
tionship between the quality of life and the disease duration, the type of MS and the functional state. The second goal was to 
compare the questionnaires in order to assess the quality of life in patients with MS. 
Material and methods: The study involved 35 consecutive patients with a clinical diagnosis of multiple sclerosis. Quality of life 
was assessed using the SF-36 and MSIS-29 questionnaires. To assess the patients' functional state the Timed Up & Go test, De 
Souza scale and a 4-test balance scale were used. 
Results: The mean scores of all subscales of the SF-36 were below the norm in the study group. There was a strong positive cor-
relation between the results of Physical Functioning (PF), Role Physical (RP) and Physical Summary Component (PSC) and the results 
of the four-step balance scale and the De Souza scale, as well as a strong negative correlation between the PF, RP, PSC and the 
Timed Up & Go results. The longer the duration of the disease was, the lower the scores assessed on the PF and PSC subscales were. 
Conclusion: 1. A longer duration of the disease and a worse functional state, lowers the quality of life of patients with multiple 
sclerosis. It seems that this group of patients requires more support from formal and informal caregivers and institutions within 
the health care system. 2. A significant correlation between the results obtained in patients with MS in the SF-36 and MSIS-29 
questionnaires, suggests that using them alternatively in the assessment of some areas of the quality of life may be justified.  
 
Słowa kluczowe 
stwardnienie rozsiane, jakość życia 
 
Streszczenie 
Wstęp: Stwardnienie rozsiane jest przewlekłą chorobą demielinizacyjną ośrodkowego układu nerwowego. Na stan funkcjonalny 
i psychiczny chorego wpływają takie czynniki jak: postać stwardnienia rozsianego, czas od diagnozy, wsparcie ze strony rodziny 
oraz wiele innych indywidualnych cech. Postępujący i długotrwały charakter choroby prowadzi z czasem do obniżenia jakości 
życia pacjentów oraz stopniowego pogarszania się ich stanu funkcjonalnego. 
Cel pracy: Ocena jakości życia pacjentów ze stwardnieniem rozsianym oraz określenie zależności pomiędzy jakością życia  
a: postacią stwardnienia rozsianego, czasem trwania choroby oraz sprawnością funkcjonalną, a także porównanie kwestionariu-
szy do oceny jakości życia u chorych na stwardnienie rozsiane. 
Materiał i metody: W badaniu wzięło udział 35 pacjentów z potwierdzoną diagnozą stwardnienia rozsianego. Jakość życia oce-
niana była za pomocą kwestionariusza SF-36 oraz MSIS-29. Oceniano także sprawność funkcjonalną pacjentów testem Timed 
Up&Go, na skali DeSouza oraz na 4-etapowej skali równowagi. 
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INTRODUCTION  
 
Sclerosis Multiplex (SM) is a chronic 
demyelinating disease of the central 
nervous system. On the basis of the 
estimates of the International Multi-
ple Sclerosis Federation (IMSF) for the 
year 2008 it resulted that almost two 
million people worldwide suffer from 
MS. Almost a half of that number are 
inhabitants of: the USA (400000), Rus-
sia (250000) and Germany (122000)1. 
The greatest incidence of illness has 
been noted in Canada – 240 cases of 
MS for every 100000 inhabitants. While 
amongst the inhabitants of countries 
such as China, India or South Korea 
the incidence is minute and does not 
exceed 3.3 cases per 100000 inhabi-
tants1. In Poland the number suffe-
ring from MS is estimated at around 
50000, with which the number of fe-
male patients is double that of men1. 
The aggregate of MS symptoms and 
their intensification is the decisive 
factor affecting the quality of pa-
tients’ lives, therefore it is important 
to here mention what disturbances 
may occur during the course of the 
illness. The symptoms of the disease 
occur most often between the age of 
20 and 40, however in recent years 
there is an evident rise in the number 
of cases of MS commencing at the age 
of ten or during puberty. The young-
est patient described in the subject 
literature was only 2 years old, how-
ever the majority of children to be 
diagnosed are in their teens2. In Po-
land the average patient age at diag-
nosis is 33.61. 
As a result of the fact that the fo-
cuses of demyelinations may occur in 
various parts of the nervous system, it 
is not possible to define a single clas-
sic view of the disease, for every pa-
tient develops a set of individualised 
symptoms. The most frequent symp-
tom are pyramidal paresis, most fre-
quently of a para-, tri- or tetra-paresis 
nature. This quickly takes on a spastic 
character, with excessive deep re-
flexes and the presence of pathological 
symptoms3. Another frequent symp-
tom are disturbances to coordination 
of a cerebellar ataxia character. These 
result from damage to the brain and/
or connections of the brain with nu-
clei of the medulla oblongata. The 
most frequent pathologies connected 
with the presented damage include: 
dysmetria, adiadochokinesis, ataxic 
gait, intention tremor as well as 
scanned speech4. Disturbance to the 
sense of feeling in the course of MS 
appears in the form of numbness, 
paraesthesia, pain and a weakening of 
various localised feeling. There may 
also occur a sensation of being bound/
restricted, awkwardness with hands, 
with correct muscle strength, Lher-
mitte’s symptom as well as neuralgia 
of the trigeminal nerve5. 
Another frequent symptom of MS is 
retrobulbar inflammations of the op-
tic nerve. These manifest themselves 
through disturbances to vision, pain-
ful movements of the eye ball, distor-
tion in the seeing of colours; this may 
partially result in a loss of sight in the 
eye in which the inflammation oc-
curs. According to data from Oxford 
University, 50% of those suffering 
from MS more than likely will experi-
ence inflammation of the optic nerve 
during the course of their life. If it oc-
curs still prior to the diagnosis of Mul-
tiple Sclerosis, while in the MRI image 
there are not seen demyelinating 
changes, then the risk of suffering 
from MS is less than 10%. However, in 
the case of the presence of typical 
changes in the MRI, the risk increases 
to about 80%6. Non-retention of urine 
is the next troublesome symptom of 
MS. Research conducted on a group of 
120 patients with MS showed that dis-
turbances in the functioning of the 
lower urinary tracts, which include 
non-retention of urine, urine reten-
tion as well as pollakiuria may be the 
first symptoms of MS. Intensification 
of these disturbances increase along 
with the disease’s progression and 
after 10 years from diagnosis, 80% of 
patients admit to problems with their 
bladder. This has a marked influence 
on the quality of life as well as causing 
discomfort in social contacts7. A large 
group of MS symptoms are distur-
bances to the cognitive functions. 
These occur in 40-65% of patients8. 
Their intensification may depend on 
the degree of brain atrophy, the size 
of the area covered by demyelination 
as well as the number of changes in 
the non-damaged brain tissue. The 
chief manifestations of cognitive defi-
ciencies are: disturbances in memory 
(chiefly operational and long-term) 
and attention span, abstract thought, 
performance functions as well as psy-
chomotor sluggishness8. One of the 
symptoms that often appears in MS is 
fatigue syndrome. On average 50-60% 
of patents consider it to be the factor 
most damaging to their quality of life, 
making it difficult to take up or con-
tinue professional work as well as af-
fecting an ability to function socially9. 
This is characterised by: apathy,  
a lack of energy, exhaustion, indiffer-
ence and boredom. Fatigue syndrome 
differs across the course of MS from 
ordinary tiredness that is the result of 
intensive physical exertion. It may be 
defined as ‘pathological exhaustion’, 
having an impact on everyday active-
ness, social life and professional ac-
tivities. It is important, however, not 
to confuse fatigue syndrome with de-
pression, in which tiredness may be 
one of the symptoms9. According to 
research around 50% of those suffe-
12 
Wyniki: Średnie wyniki wszystkich podskal kwestionariusza SF-36 w badanej grupie osiągnęły wartości poniżej normy. Odnoto-
wano silne dodatnie korelacje pomiędzy wynikami Physical Functioning (Aktywność fizyczna i jej ograniczenia spowodowane sta-
nem zdrowia), Role Physical (Ograniczenia w pełnieniu ról społecznych z powodu problemów w funkcjonowaniu fizycznym)  
i Physical Summary Component (PSC), a rezultatami 4-etapowej skali równowagi oraz skali De Souza, a także silną ujemną korela-
cję pomiędzy PF, RP PSC, a wynikami testu Timed Up&Go. Wraz z wydłużaniem się czasu trwania choroby znamiennie obniżały 
się wyniki na podskalach PF oraz PSC. 
Wnioski: 1. Dłuższy czas trwania choroby oraz gorsza sprawność funkcjonalna, wpływa na obniżenie poziomu jakości życia pa-
cjentów ze stwardnieniem rozsianym. Należy spodziewać się, że ta grupa docelowa wymagała będzie szczególnego wsparcia ze 
strony formalnych i nieformalnych opiekunów oraz instytucji opieki zdrowotnej. 2. Silna korelacja pomiędzy wynikami uzyska-
nymi u chorych na stwardnienie rozsiane w kwestionariuszu SF-36 oraz MSIS-29, sugeruje, że stosowanie ich zamiennie do oce-
ny niektórych obszarów jakości życia może być uzasadnione.  
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ring from SM experience depression 
during the course of their life10. This is 
one of the main factors influencing 
quality of life. This may result in  
a progression in cognitive distur-
bances, often weakening the relations 
a patient has with others, sometimes 
resulting in a failure to adhere to the 
regular prescribed medicine intake of 
drugs designed to modify the course 
of MS, and consequently a progres-
sion in the disease itself10. 
 
Quality of life in patients  
with Multiple Sclerosis  
 
As a result of the long-term and pro-
gressive character of multiple sclero-
sis as well as the whole range of debili-
tating symptoms for a patient, those 
suffering from MS have a noticeably 
lowered quality of life (QoL) when 
compared to healthy individuals and 
even in relation to those suffering 
from other chronic illnesses like, for 
instance rheumatic joint inflamma-
tion11. Together with the duration of 
the disease and its progression the 
indicators of quality of life have a ten-
dency to decrease12. The combination 
of progressiveness and the unpredic-
tability of the disease create an un-
usually stressful picture, one strongly 
impacting on a lowering of QoL, not 
only in the patients themselves, but 
also amongst those close to them13. 
Interest in the subject of quality of life 
is connected inseparably with the in-
creasingly penetrating analysis of the 
costs of medical care as well as the 
evaluation of the effectiveness and 
efficacy of the methods of treatment 
employed. The first piece of research 
into QoL in Multiple Sclerosis was 
published in 1992 roku11. From that 
moment onwards the number of 
works on the subject of the physical, 
emotional and social consequences of 
MS has grown rapidly14-16. 
From amongst the universal ques-
tionnaires most often used in the 
evaluation of quality of life in MS pa-
tients one may mention Medical Out-
come Study 36-Item Short Form Health 
Survey (SF-36), Life Satisfaction Ques-
tionnaire (LSQ) as well as the Quality of 
Well-Being Scale (QWBS)17. 
There also exist many specific in-
struments for measuring quality of 
life in MS. The most frequently used 
are: Functional Assessment of Multiple 
Sclerosis (FAMS), Multiple Sclerosis Qual-
ity of Life Instrument (MSQoL-54), 
which came about through the addi-
tion of 18 questions characteristic for 
MS to the SF-36 questionnaire, Multiple 
Sclerosis Functional Composite (MSFC), 
Multiple Sclerosis Impact Scale (MSIS-
29), Multiple Sclerosis Quality of Life In-
ventory (MSQLI) or Health-Related Qua-
lity of Life Questionnaire for Multiple Scle-
rosis (HRQOL-MS)18. 
Those suffering from MS speak of  
a lower quality of life than the popu-
lation as a whole, but they also obtain 
worse results on quality of life scales 
when measured against other chronic 
diseases such as rheumatic joint in-
flammation, illnesses of bowel inflam-
mation or psychic illnesses11,19. 
Several factors may influence this 
lowered level of life quality. Amongst 
these Benito-Leon et al.14 have distin-
guished: 
– troublesome symptoms of the dis-
ease, 
– usually the young age at which the 
diagnosis is made, 
– the unpredictable course of the dis-
ease, which affects the sense of con-
trol,  
– the lack of any possibility for a com-
plete cure, 
– imperfection in existing methods 
of treatment, with side effects in-
clusive as well as the uneven access 
to the latest methods of treatment 
as a result of the costs involved. 
A positive influence on the quality of 
life of SM patients is exerted by, 
among other things, the maintaining 
of independence in daily activities as 
equally in the taking of decisions, the 
sense of support from both family and 
friends as well as society together 
with medical personnel20. Amongst 
the factors that can aid in the im-
provement of QoL indicators in these 
patients is the undertaking of physi-
cal activity as well as, which is more 
important, self evaluation of the sense 
of one’s own abilities21,22.  
 
AIM OF THE WORK  
 
The aim of the present work was to 
evaluate the quality of life of patients 
with Multiple Sclerosis as well as de-
fining the dependence between quality 
of life and such factors as: sex, disease 
duration, the form of MS as well as 
the physical functionality of the pa-
tient, and also to undertake a com-
parative look at quality of life ques-
tionnaires for patients with Multiple 
Sclerosis.  
 
MATERIALS 
 
In the tests that were conducted from 
the 6th of November 2012 to the 12th of 
April 2013, participated 35 MS pa-
tients comprising 23 women and 12 
men. These were patients of a Cracow 
clinic providing outpatient rehabilita-
tion treatment for those suffering 
from Multiple Sclerosis. Prior to the 
commencement of tests each of the 
patients gave their oral consent to 
participate in the proceedings. 
Qualified to the tests were patients: 
with diagnosed Multiple Sclerosis 
(one carried out by a neurologist); and 
in whom, for the duration of the re-
search, there did not occur a new re-
lapse of the disease requiring the ap-
plication of steroid infusions. 
The most numerous group in the 
sample tested were individuals who 
had diagnosed a primary-progressive 
MS (PPMS) (40%). Not noticeably 
fewer, for constituting 36% of those 
tested, were patients in whom there 
 
Description of the project sample  
Feature  n=35 
Age (x±OS) 45,9 ±12,1 
Men 12 (34,3%) 
Women 23 (65,7%) 
Disease duration length (x±OS) 10,8 ±9,3 
n – number of testees, SD – Standard deviation  
Table 1 
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had been diagnosed a relapsing-re-
mitting MS (RRMS). The frequency in 
the appearance of a secondary-pro-
gressive MS (SPMS) was 21%, while  
a progressive-relapsing MS (PRMS) 3%. 
 
METHODS 
 
Quality of life was measured by means 
of the MSIS-29 questionnaire and the 
SF-36 questionnaire. The required li-
cence to use the SF-36 questionnaire 
for research was obtained from Qual-
ity Metric Incorporation, which holds 
the copyright to the said. An official 
translation of the questionnaire into 
Polish was used in the research, this 
being obtained equally from Quality 
Metric Incorporation. Permission was 
also gained from the author of the 
MSIS-29 questionnaire to use the 
questionnaire for the duration of the 
research. Additionally before the tests 
were commenced the patients com-
pleted a personal questionnaire which 
contained, among others, questions 
on the subject of sex, education, pro-
fessional status, the requirements for 
support from third parties, whether 
they were members of organisations 
grouping Multiple Sclerosis sufferers.  
The Multiple Sclerosis Impact Scale 
(MSIS-29) questionnaire is a research 
instrument specific to Multiple Scle-
rosis, and published by Hobarta et 
al.18 in 2001. It allows one to evaluate 
the influence of Multiple Sclerosis on 
the quality of life from the patient’s 
perspective. MSIS-29 is composed of 
two parts – the first of these conta-
ining 20 questions concerns the effect 
of MS on the physical aspect of the 
patient’s life, the second, composed of 
9 questions, evaluates the influence of 
MS on the psychic state. The higher 
the result obtained in the test the 
worse the patient’s quality of life23. 
The Medical Outcome Study 36-Item 
Short Form Health Survey (SF-36) is  
a universal instrument applied in the 
measurement of a subjective evalua-
tion of the state of health. It tests two 
aspects of quality of life (the physical 
and the mental) by means of 36 ques-
tions grouped into 8 sub-scales: phy-
sical activeness and its limitation 
brought about by a state of health 
(Physical Functioning, PF), limitation in 
fulfilling social roles as a result of prob-
lems in physical functioning (Physical 
Role Limitation, RP), the experiencing 
of pain (Bodily Pain, BP), general state 
of health (General Health, GH), the 
subjective evaluation of vigour and 
energy levels (Vitality, VT), social 
functioning (Social Functioning, SF), 
emotional functioning and its impact 
on social activity (Role-Emotional, RE) 
as well as psychic health (Mental 
Health, MH). The greater the number 
of points obtained the better the sub-
jective quality of life24. 
Functional fitness was evaluated by 
means of the following tests: the 
Timed Up&Go, a four-stage scale of 
balance and the De Souza Scale. The 
Test Timed Up and Go serves in test-
ing balance as well as functional mo-
bility, which impacts on the basic 
abilities to move about. This is a test 
used chiefly in the evaluating of the 
risk of falls in the elderly25, however 
its usefulness in the evaluation of falls 
in MS patients has also been proven. 
Those tested were required to: stand 
up from a chair, walk 3 metres, turn 
round, return and sit down in the 
chair 26. The Four-test balance scale con-
tains 4 static equivalent tasks of a ris-
ing level of difficulty, carried out 
without additional instrumental aids. 
The test should not involve a trial 
run, while each task is to be per-
formed with footwear. The teste re-
ceives 0 points if they are not able to 
stand with their feet together for 10 
seconds. The greatest number of 
points (4), are gained by a patient who 
can stand on one leg for 30 seconds2. 
The De Souza Scale serves in the 
evaluation of functional disability and 
mobility limitation in individuals with 
MS. It comprises 11 functions, which 
are ranked in order of those the earli-
est obtained in the course of man’s 
motor development, to the most diffi-
cult motor tasks. The greatest num-
ber of points (11 pkt.) are obtained by 
a patient who is able to hold them-
selves in a one-legged position for 5 
seconds on the lower limb under ob-
servation. The subsequent tasks with 
fewer points involve, among other 
activities, getting up from lying on 
one’s back to standing without the 
support of the arms (9 pts), standing 
from a squatting position without the 
support of the arms (7 pts), walking  
a distance of 20 metres aided (5 pts), 
turning around from a position of ly-
ing on one’s back in both directions  
(3 pts) or squatting without support 
for 60 seconds, for which the patient 
is awarded 1 point28. 
 
Statistical analysis 
 
The detailed results of the SF-36 ques-
tionnaire were calculated by means of 
the Health Outcomes Scoring Soft-
ware 4.5 program. Further statistical 
analysis was conducted using Statis-
tica 10. The descriptive statistics were 
used in the characterisation of the 
tested sample. The remaining analysis 
was conducted using t-Student tests 
for the independent groups while in 
the case of those not fulfilling its pre-
requisites a non-parametrical equiva-
lent was used. All the results were 
analysed at the level of a statistical 
significance of p<0.05. 
 
RESULTS 
 
The results obtained in the MSIS–29 
were converted in such a way so that 
the greater quantity of points ob-
tained represented a higher quality of 
life, as was the case in the SF-36 ques-
tionnaire.  
It was shown that the SF-36 and 
MSIS-29 questionnaires displayed  
a strong correlation between the 
matching areas of quality of life (at 
the level of r=0.65). As a result in fur-
ther calculations the results obtained 
by means of SF-36 were used, which 
allowed one to evaluate more aspects 
of quality of life.  
For the needs of analysing the SF-36 
questionnaire the NBS (Norm - Based 
Score) results were taken into consid-
eration. MS testees evaluated each of 
the tested aspects of quality of life de-
tailed in the SF-36 questionnaire 
which were below the normative 
value.  
In the Timed Up&Go test the aver-
age result was 9.89 seconds (OS=6.53). 
On the De Souza Scale the greatest 
number of patients obtained a result 
of 11 points (3-11). The most fre-
quently gained result on the 4-stage 
balance scale was 3 points (0-4). 
In Table 2 are presented the aver-
age values obtained by the testees in 
the individual sub-scales of the SF-36 
questionnaire in relation to: sex, dis-
ease duration, the type of MS as well 
as the results of functional fitness 
tests. No characteristic differences in 
the results obtained by women and 
14 
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men on any of the sub-scales were 
found (p>0,05). The patients who had 
been ill for a shorter time (≤10 years) 
only obtained a statistically signifi-
cantly better result than those who 
had been ill for over 10 years in the 
BP sub-scale (p=0.04). In patients with 
a RRMS and a progressive type there 
was not noted any characteristic dif-
ferences (p>0.05). In the Timed Up&Go 
test patients who obtained a time of 
less than 10 seconds, obtained more 
points in each of the SF-36 sub-scales 
than those individuals who required 
more than 10 seconds to complete the 
test. Statistically significant were the 
differences PF, RP and PSC. Patients 
who obtained on the De Souza scale 
over 6 points also obtained better re-
sults in all the areas of the SF-36 ques-
tionnaire, when compared to those 
who gained 6 or fewer points. Statisti-
Figure 1 
The Comparison of the medial results in the sub scales of the SF 36 questionnaire 
within  the sample 
Table 2 
Medial results in the subscales of the SF 36 questionnaire 
  PF RP BP GH VT SF RE MH PSC MSC 
Sex                     
Women 39,0 38,5 42,2 43,6 48,6 41,2 40,9 43,9 40,3 45,2 
Men 43,3 39,8 47,9 40,8 46,9 40,2 42,0 41,7 44,0 42,3 
p NI NI NI NI NI NI NI NI NI NI 
Duration of SM                      
≤10 years  42,2 39,9 46,6 42,5 48,1 39,9 43,2 44,1 42,8 44,5 
> 10 years 37,9 37,4 40,5 43,0 47,9 42,3 38,3 41,7 39,7 43,7 
p NI NI p=0,04 NI NI NI NI NI p=0,04 NI 
Type of SM                     
RR 38,7 38,4 41,0 40,7 44,9 37,7 37,9 40,2 40,4 40,5 
PP+WP 40,1 37,7 45,2 42,5 48,8 41,6 41,9 44,1 41,0 45,5 
p NI NI NI NI NI NI NI NI NI NI 
Timed Up&Go                     
≤10 seconds  43,6 41,1 44,5 43,2 49,0 41,7 43,1 44,0 43,4 44,9 
>10 seconds 32,3 32,8 43,0 40,5 42,7 38,1 34,7 36,9 37,6 39,1 
p p=0,005 p=0,01 NI NI NI NI NI NI p=0,03 NI 
De Souza Scale                      
≤ 6 pts 27,4 29,1 40,4 38,2 45,9 36,0 30,1 39,1 33,3 40,2 
> 6 pts 42,2 40,2 44,6 43,2 48,3 41,5 42,7 43,7 42,7 44,7 
p p=0,005 p=0,01 NI NI NI NI p=0,047 NI p=0,01 NI 
4-stage balance scale                      
≤2 pts 31,4 32,0 42,8 42,9 46,7 38,4 36,4 42,7 35,9 44,0 
>2 pts 43,6 41,4 44,6 42,6 48,5 41,7 42,9 43,3 43,6 44,3 
p p=0,001 p=0,002 NI NI NI NI NI NI p=0,003 NI 
* higher results means a better quality of life  
PP - Primary-Progressive MS, RR – Relapsing-Remitting MS, SP – Secondary-Progressive MS, MS - Multiple Sclerosis, 
PF - Physical Functioning, RP - Role Physical, BP - Bodily Pain, GH - General Health, VT - Vitality, SF - Social Functioning, RE - Role Emotional,  
MH - Mental Health, PCS - Physical Component Summary, MCS - Mental Component Summary 
NS - non significance 
15 
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PF - Physical Functioning, RP - Role Physical, BP - Bodily Pain, GH - General Health, VT - Vitality,  
SF - Social Functioning, RE - Role Emotional, MH - Mental Health, PCS - Physical Component Summary, 
MCS - Mental Component Summary 
R
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 Norm 
cally significant were the differences 
in the sub-scales PF, RP, RE and PSC 
(p<0.05). Those who obtained over 2 
points on the 4-stage balance scale 
gained significantly better results in 
the sub-scales of PF, RP and PCS, than 
did patients who on the 4-stage ba-
lance scale gained 2 or fewer points 
(p<0.05). 
The correlation between each of 
the sub-scales in the SF-36 question-
naire, the duration of the disease, and 
the results of the tests into functional 
fitness were evaluated by means of 
the Spearman coefficient correlation 
rho (Table 3). The results obtained on 
the De Souza Scale correlate favoura-
bly with the PF, RP, RE and PSC sub-
scales. High indicators of correlation 
were obtained for PF (r= 0.54), RP 
(r=0.603) and PSC (r=0.502). A positive 
coefficient of correlation appeared 
equally amongst the results of the  
4-stage balance scale and the sub-
scales of PF (r=0.557), RP (r=0.565) and 
PSC (r=0.616). Additionally the results 
of the Timed Up&Go test negatively 
correlate with the results of the sub-
scales PF, RP, RE and PSC. High indica-
tors of correlation were obtained for 
PF (r=-0.603), RP (r=-0.466) and PSC 
(r=-0.570). In addition, there was noted 
a significant correlation between a lon-
ger duration of SM and poorer PF 
(r=-0.358) and PSC (r=-0.351) results. 
 
DISCUSSION 
 
The results of our research reiterate 
the tendency observed earlier whe-
reby patients with MS in their evalua-
tion of aspects of quality of life as de-
tailed in the SF-36 rate themselves 
lower than the accepted norm. More 
than likely this results from the spe-
cifics of the disease and its negative 
impact on daily life. Similar results 
have been obtained in, among other 
places, Australia and Italy12,29. 
The results of the research of Dru-
lovic et al.30, conducted on 156 pa-
tients who evaluated their quality of 
life by means of the SF-36 question-
naire, did not show any significant 
differences between the results ob-
tained in the male and female groups. 
Similar results were also obtained by 
Polish researchers, who by means of 
the SF-36 questionnaire among other 
things, tested 64 individuals with 
diagnosed Multiple Sclerosis31. They 
evaluated the impact of socio-demo-
graphic factors on patient quality of 
life. The results obtained as a result of 
these considerations pointed to the 
absence of a significant influence on 
the part of the gender of those tested 
as well as their place of abode on the 
subjective evaluation of quality of life. 
High economic (financial) status was 
conducive to a higher evaluation of 
quality of life in the PF (Physical Func-
tioning) and GH (General Health) sub-
scales31. The results of our own tests 
also did not indicate differences in the 
evaluation of quality of life amongst 
women and men suffering from MS.  
In relating to the specifics of illness 
and the varieties of its course it is 
worth considering the differences in 
the quality of patient life with the 
various forms of Multiple Sclerosis. In 
the research available there is no ab-
sence of tests which show the exis-
tence of characteristic differences be-
tween groups differentiated by the 
type of the disease. In the research by 
Drulovic et al.30, mentioned earlier, 
the average results of each of the sub-
scales in the SF-36 questionnaire, ob-
tained by patients with a progressive 
type of the disease, were lower than 
for individuals with a RRSM. For the 
sub-scales PF (Physical Functioning), RP 
(Role Physical), SF (Social Functioning) 
and RE (Role Emotional) these diffe-
rences were statistically significant30. 
Our own research did not confirm 
these notions, although this could 
possibly be connected with the small 
number of patients who were differ-
entiated by particular forms of SM.  
In our research the better fitness 
test results correlate with the above 
results obtained in the sub-scales PF 
and RP of the SF-36 questionnaire. 
This means that together with an im-
provement in the functional fitness 
state of patients there increases their 
subjective evaluation of physical fit-
ness and decreases the sense of limi-
tations brought about by their state of 
health (PF), as well as them more fa-
vourably perceiving the impact of 
their state of health on eventual limi-
tations in fulfilling social roles (RP). 
Helpful in explaining this phenome-
non appears to be the scientific report 
of Molt et al.21, who tested the de-
pendence between changes in the 
level of physical activity, patient’s 
own evaluation of physical fitness and 
ability and the quality of life of pa-
tients with a RRMS. They showed that 
it follows to consider physical activity 
and, something which appears to be 
more important, the subjective level 
of evaluation of one’s own abilities 
amongst the factors that can improve 
the indicators of QoL21,22. 
The results of the research confirm 
a significant favourable dependence 
between the time that has elapsed 
from the diagnosis of MS and a dete-
rioration in patient quality of life32. In 
our research the length of disease du-
ration only negatively correlates with 
the results of the PF sub-scale (phy-
Table 3 
The correlation between the results of the SF 36 questionnaire’s sub scales, disease duration and the results  
of the functional tests measurements 
  PF RP BP GH VT SF RE MH PSC MSC 
MS duration -0,358 -0,286 -0,318 -0,104 -0,098 0,024 -0,294 -0,078 -0,351 -0,028 
De Souza scale 0,540 0,603 0,098 0,127 0,277 0,257 0,340 0,169 0,502 0,180 
Balance scale 0,557 0,565 0,192 0,176 0,168 0,232 0,259 -0,011 0,616 0,011 
Timed Up&Go -0,603 -0,466 -0,353 -0,172 -0,292 -0,262 -0,376 -0,216 -0,570 -0,196 
PF - Physical Functioning, RP - Role Physical, BP - Bodily Pain, GH - General Health, VT - Vitality, SF - Social Functioning, RE - Role Emotional,  
MH - Mental Health, PCS - Physical Component Summary, MCS - Mental Component Summary, MS - Multiple Sclerosis, Timed Up&Go  
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sical activity and its limitation result-
ing from the state of health), and also 
with the part of the questionnaire on 
physical fitness as a whole (PSC). This 
might be the result of the fact that the 
functional state of the patients con-
stantly deteriorated with the passing 
of time, affecting the physical aspect 
of QoL. However, a chronic disease 
allows for a gradual development in 
strategies of coping with the impact 
of the disease on the psychological 
aspects of quality of life33. 
Despite certain limitations in the 
research we conducted, one may con-
clude from following the subject lit-
erature that the quality of life of pa-
tients with Multiple Sclerosis is placed 
at a lower level than the normative 
values for the general population and 
that this depends on the degree of the 
physical functionability of the pa-
tients themselves.  
 
CONCLUSIONS 
 
1. Patients with Multiple Sclerosis 
display a lowered level of quality of 
life. The results of the SF-36 ques-
tionnaire correlate well with the 
measured level of functional fit-
ness and the length of the disease’s 
duration. This means that longer 
disease duration and worse func-
tional fitness influence the lowered 
level of quality of life for Multiple 
Sclerosis patients. It follows to ex-
pect that this group will require 
special support on the part of for-
mal and informal carers as well as 
from health service institutions.  
2. The significant correlation between 
the results obtained for patients 
with SM in the SF-36 questionnaire 
as well as in the MSIS-29, suggest 
that accordingly their interchange-
ability in the evaluating of certain 
areas of quality of life may be justi-
fied. The MSIS-29 questionnaire, 
which is shorter as well as accor-
ding to researchers contains less 
ambiguous questions, appears to 
be the better choice.  
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